Literature DB >> 6292743

Does presynaptic regulation of sympathetic transmission occur within a limited range of neuronal activity?

A R Wakade, T D Wakade.   

Abstract

Recent reports indicate that the presynaptic negative feedback mechanism involved in regulating sympathetic neurotransmission is only functional within a narrow range of neuronal activity. The specific aim of this report is to examine the release of sympathetic transmitter at varying frequencies of stimulation, and the effects of alpha-adrenoceptor antagonists on the overflow. The experiments were carried out in the 3H-noradrenalin-labeled heart of the guinea pig. The overflow of tritium (per pulse) increased from a stimulation frequency of 0.125 to 10 Hz and declined at 30 Hz. Phentolamine or yohimbine produced facilitation of the overflow from 0.125 to 10 Hz; the effect was more pronounced at lower frequencies of stimulation. We conclude that the presynaptic alpha-adrenoceptor-mediated negative feedback mechanism operates over a wide range of cardiac sympathetic nerve activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292743     DOI: 10.1007/bf00586354

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  16 in total

1.  The output of sympathetic transmitter from the spleen of the cat.

Authors:  G L BROWN; J S GILLESPIE
Journal:  J Physiol       Date:  1957-08-29       Impact factor: 5.182

2.  Pre- and postsynaptic components in effect of drugs with alpha adrenoceptor affinity.

Authors:  K Starke; T Endo; H D Taube
Journal:  Nature       Date:  1975-04-03       Impact factor: 49.962

3.  Frequency-dependence of 3H-noradrenaline secretion from human vasoconstrictor nerves: modification by factors interfering with alpha-or beta-adrenoceptor or prostaglandin E2 mediated control.

Authors:  L Stjärne; J Brundin
Journal:  Acta Physiol Scand       Date:  1977-10

4.  Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine.

Authors:  K Starke; E Borowski; T Endo
Journal:  Eur J Pharmacol       Date:  1975-12       Impact factor: 4.432

5.  A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation.

Authors:  K Löffelholz; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

6.  Alpha-adrenoceptor mediated feed-back control of sympathetic neurotransmitter secretion in guinea-pig vas deferens.

Authors:  L Stjärne
Journal:  Nat New Biol       Date:  1973-02-07

7.  Relation between the rate of stimulation and the quantity of noradrenaline liberated from sympathetic nerve endings in the isolated perfused spleen of the cat.

Authors:  W Haefely; A Hürlimann; H Thoenen
Journal:  J Physiol       Date:  1965-11       Impact factor: 5.182

8.  Inhibition of noradrenaline release by adenosine.

Authors:  A R Wakade; T D Wakade
Journal:  J Physiol       Date:  1978-09       Impact factor: 5.182

9.  Release of noradrenaline by splenic nerve stimulation and its dependence on calcium.

Authors:  S M Kirpekar; Y Misu
Journal:  J Physiol       Date:  1967-01       Impact factor: 5.182

10.  Release of endogenous noradrenaline from an isolated muscular artery. Release of endogenous noradrenaline from an isolated muscular artery.

Authors:  C Bell; M Vogt
Journal:  J Physiol       Date:  1971-06       Impact factor: 5.182

View more
  5 in total

1.  Role of auto-inhibitory feed-back in cardiac sympathetic transmission assessed by simultaneous measurements of changes in 3H-efflux and atrial rate in guinea-pig atrium.

Authors:  J A Angus; A Bobik; G P Jackman; I J Kopin; P I Korner
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

2.  Effects of desipramine, trifluoperazine and other inhibitors of calmodulin on the secretion of catecholamines from the adrenal medulla and postganglionic sympathetic nerves of the salivary gland.

Authors:  A R Wakade; T D Wakade
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

3.  Further study of prerequisites for the enhancement by alpha-adrenoceptor antagonists of the release of noradrenaline.

Authors:  N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

4.  Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuation.

Authors:  Gary L Aistrup; Roger Villuendas; Jason Ng; Annette Gilchrist; Thomas W Lynch; David Gordon; Ivan Cokic; Steven Mottl; Rui Zhou; David A Dean; J Andrew Wasserstrom; Jeffrey J Goldberger; Alan H Kadish; Rishi Arora
Journal:  Cardiovasc Res       Date:  2009-05-20       Impact factor: 10.787

5.  The determination of presynaptic pA2 values of yohimbine and phentolamine on the perfused rat heart under conditions of negligible autoinhibition.

Authors:  H Fuder; E Muscholl; R Spemann
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.